Context: Bariatric surgery can induce remission in a high proportion of severely obese patients with type 2 diabetes mellitus (T2DM). Objective:Our objective was to investigate predictors andmechanisms of surgery-induced diabetes remission. Patients and Setting: Forty-three morbidly obese subjects (body mass index 45.6 5.0 kg/m2 ), 32 with T2DM and 11 nondiabetic [normal glucose tolerance (NGT)], participated at a clinical research center. Intervention: Patients underwent Roux-en-Y gastric bypass. Main Outcome Measures: Diabetes remission and -cell function were evaluated. Results: Subjects were tested before and 45 d and 1 yr after surgery. Weight decreased similarly in T2DM and NGT (39 kg at 1 yr, P 0.0001). Insulin sensitivity improved in both groups in proportion to the changes in body mass index but remained lower in T2DM than NGT (386 91 vs. 479 89 ml/min m2 , P 0.01). Based on glycosylated hemoglobin and oral glucose testing, diabetes had remitted in nine patients at 45 d and in an additional 16 at 1 yr. In T2DM, -cell glucose sensitivity increased early after surgery but was no further improved and still abnormal at 1 yr [median, 48 (coefficient interval, 53) pmol/min m2 mM vs. median, 100 (coefficient interval, 68) of NGT, P 0.001]. Baseline-cell glucose sensitivity wasprogressivelyworsein early remitters,late remitters, and nonremitters (median, 54[coefficient interval, 50] vs. median, 22[coefficient interval, 26] vs. median, 4[coefficient interval, 10] pmol/min m2 mM) and, by logistic regression, was the only predictor of failure [odds ratio for bottom tertile 7.9 (95% confidence interval 1.2-51.9); P 0.03]. Conclusions: In morbid obesity, Roux-en-Y gastric bypass causes rapid and profound metabolic adaptations; insulin sensitivity improves in proportion to the weight loss, and -cell glucose sensitivity increases independently of weight loss. Over a period of 1 yr after surgery, diabetes remission depends on the starting degree of -cell dysfunction.

The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery

Mari A;
2011

Abstract

Context: Bariatric surgery can induce remission in a high proportion of severely obese patients with type 2 diabetes mellitus (T2DM). Objective:Our objective was to investigate predictors andmechanisms of surgery-induced diabetes remission. Patients and Setting: Forty-three morbidly obese subjects (body mass index 45.6 5.0 kg/m2 ), 32 with T2DM and 11 nondiabetic [normal glucose tolerance (NGT)], participated at a clinical research center. Intervention: Patients underwent Roux-en-Y gastric bypass. Main Outcome Measures: Diabetes remission and -cell function were evaluated. Results: Subjects were tested before and 45 d and 1 yr after surgery. Weight decreased similarly in T2DM and NGT (39 kg at 1 yr, P 0.0001). Insulin sensitivity improved in both groups in proportion to the changes in body mass index but remained lower in T2DM than NGT (386 91 vs. 479 89 ml/min m2 , P 0.01). Based on glycosylated hemoglobin and oral glucose testing, diabetes had remitted in nine patients at 45 d and in an additional 16 at 1 yr. In T2DM, -cell glucose sensitivity increased early after surgery but was no further improved and still abnormal at 1 yr [median, 48 (coefficient interval, 53) pmol/min m2 mM vs. median, 100 (coefficient interval, 68) of NGT, P 0.001]. Baseline-cell glucose sensitivity wasprogressivelyworsein early remitters,late remitters, and nonremitters (median, 54[coefficient interval, 50] vs. median, 22[coefficient interval, 26] vs. median, 4[coefficient interval, 10] pmol/min m2 mM) and, by logistic regression, was the only predictor of failure [odds ratio for bottom tertile 7.9 (95% confidence interval 1.2-51.9); P 0.03]. Conclusions: In morbid obesity, Roux-en-Y gastric bypass causes rapid and profound metabolic adaptations; insulin sensitivity improves in proportion to the weight loss, and -cell glucose sensitivity increases independently of weight loss. Over a period of 1 yr after surgery, diabetes remission depends on the starting degree of -cell dysfunction.
2011
INGEGNERIA BIOMEDICA
Istituto di Neuroscienze - IN -
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/47345
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 161
  • ???jsp.display-item.citation.isi??? 150
social impact